Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 6,187 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Medication Group Clear all

Conditions: Diabetes Mellitus, Type 2
Interventions: SomaSignal Informed Medical Management SSCVD, Standard of Care; Diagnostic Test · Other
Lead sponsor: Emory University; Other
Eligibility: 40 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: Atlanta, Georgia

Conditions: Acne Vulgaris
Interventions: Adapalene, frequent visits, electronic reminder, Parent reminder, Standard of care; Drug · Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Bronchopulmonary Dysplasia
Interventions: Infasurf, Pulmicort, Sham; Drug · Other
Lead sponsor: East Carolina University; Other
Eligibility: 24 Weeks to 28 Weeks
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Mantle Cell Lymphoma
Interventions: Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy, Computed Tomography, Positron Emission Tomography, Rituximab, Rituximab and Hyaluronidase Human; Procedure · Biological
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years to 70 Years
Enrollment: 689 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 374
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 236 more

Conditions: Sickle Cell Disease
Interventions: bb1111; Genetic
Lead sponsor: Genetix Biotherapeutics Inc.; Industry
Eligibility: 2 Years to 50 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 9
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Boston, Massachusetts + 6 more

Conditions: Surgical Wound Infections
Interventions: Vancomycin, Placebo (Saline Solution); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Gastrointestinal Dysfunction
Interventions: Neostigmine, Glycopyrrolate, Saline (Placebo), High Resolution Colonic Manometry; Drug · Other · Device
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Spinal Cord Injuries, Type 2 Diabetes
Interventions: Semaglutide Injectable Product, Placebo; Drug · Other
Lead sponsor: Marzieh Salehi; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: San Antonio, Texas

Conditions: Knee Osteoarthritis, Primary Total Knee Arthroplasty, Physical Therapy, Pain, Knee Extension
Interventions: Ropivacaine, Interspace Between the Popliteal Artery and Capsule of the Knee (iPACK) Block, Saline; Drug · Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV Antibodies
Interventions: VRC-HIVMAB091-00-AB, rHuPH20; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Schizophrenia
Interventions: lamotrigine; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 21
States / cities: Little Rock, Arkansas • Garden Grove, California • Glendale, California + 17 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Glooko's mobile application; Device
Lead sponsor: Glooko; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 4
States / cities: Concord, California • Elk Grove, California • San Diego, California + 1 more

Conditions: Type 2 Diabetes
Interventions: Peers LEAD, HLWD; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Cardiovascular Diseases
Interventions: Point of Care, Population Management; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • DeKalb, Illinois • Oak Brook, Illinois + 2 more

Conditions: Pre-diabetic State, Overweight, Obesity
Interventions: Clinical referral to diabetes prevention lifestyle, Clinical referral to group diabetes prevention lifestyle; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 25 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Binge Eating Disorder
Interventions: dasotraline 4mg, dasotraline 6mg, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 491 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 50
States / cities: Phoenix, Arizona • Beverly Hills, California • Encino, California + 44 more

Conditions: Breast Cancer, Postoperative Pain, Anesthesia, Nerve Block
Interventions: PEC I/II blocks by anesthesiologist - pre-operative, PEC I/II blocks by surgeon - intra-operative; Procedure
Lead sponsor: Melinda Seering; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Human Immunodeficiency Virus, HIV Seropositivity
Interventions: iTransition; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 3
States / cities: Atlanta, Georgia • Philadelphia, Pennsylvania

Conditions: Alcohol Use Disorder (AUD), Substance Use Disorders
Interventions: W-SUDs, Digitally-delivered Psychoeducation; Device · Other
Lead sponsor: Woebot Health; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pediatric Cancer
Interventions: COMPRENDO Peer Navigation Intervention; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Birmingham, Alabama • San Diego, California • San Francisco, California + 1 more

Conditions: Cystic Fibrosis
Interventions: Motivational Interviewing, Cystic Fibrosis Education; Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 16 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoarthritis of the Knee
Interventions: honeybee venom (Apitoxin (Korea) Apitox (USA)); Drug
Lead sponsor: Apimeds, Inc.; Industry
Eligibility: 35 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 4
States / cities: Pinellas Park, Florida • Chicago, Illinois • Columbus, Ohio + 1 more

Conditions: Heart Rate Variability
Interventions: Heart Rate Variability - Biofeedback (HRV-BF), Health Promotion (HP); Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 3
States / cities: Los Angeles, California

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Carcinoma, Triple-Negative Breast Carcinoma
Interventions: Biopsy of Breast, Biospecimen Collection, Breast Surgery, Chemotherapy, Computed Tomography, Contrast Enhanced Digital Mammography, Hypofractionated Radiation Therapy, Magnetic Resonance Imaging, Positron Emission Tomography, Survey Administration, Tissue Collection, Ultrasound Imaging; Procedure · Drug · Radiation + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: Scottsdale, Arizona

Search by objective public record fields.

SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes

Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

Prevention of Neurosurgical Wound Infections

Use of High Resolution Colonic Manometry in Studying Motility

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.

Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

Glooko mHealth Advantage Study

Peers EXCEL Trial to Improve Glycemic Control

Healthy Hearts in the Heartland

Feasibility of a Partnered Approach to Prevent Diabetes

A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

Comparison of Pre-op and Post-op Pectoralis Nerve Block

iTransition Development

The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use

Multisite Implementation of COMPRENDO

Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience

Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation

Impact of Community-Based Biofeedback Program on Drug Use and Mental Health Among People Experiencing Homelessness

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer